vs
Ceribell, Inc.（CBLL）与迈心诺（MASI）财务数据对比。点击上方公司名可切换其他公司
迈心诺的季度营收约是Ceribell, Inc.的15.0倍（$371.5M vs $24.8M）。迈心诺净利率更高（-27.0% vs -54.6%，领先27.6%）。迈心诺自由现金流更多（$50.9M vs $-11.0M）
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
迈心诺（Masimo Corporation）是总部位于美国加利福尼亚州尔湾的健康科技及消费电子企业，核心产品包括面向医院及家用场景的患者监护设备、无创传感器及配套软件平台，同时也布局了消费级音频和可穿戴设备赛道。
CBLL vs MASI — 直观对比
营收规模更大
MASI
是对方的15.0倍
$24.8M
净利率更高
MASI
高出27.6%
-54.6%
自由现金流更多
MASI
多$61.9M
$-11.0M
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $24.8M | $371.5M |
| 净利润 | $-13.5M | $-100.4M |
| 毛利率 | 87.3% | 62.1% |
| 营业利润率 | -58.9% | 22.5% |
| 净利率 | -54.6% | -27.0% |
| 营收同比 | — | -26.4% |
| 净利润同比 | — | -1124.5% |
| 每股收益（稀释后） | $-0.35 | $-1.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBLLMASI
| Q4 25 | $24.8M | — | ||
| Q3 25 | $22.6M | $371.5M | ||
| Q2 25 | $21.2M | $370.9M | ||
| Q1 25 | $20.5M | $372.0M | ||
| Q4 24 | — | $600.7M | ||
| Q3 24 | $17.2M | $504.6M | ||
| Q2 24 | — | $496.3M | ||
| Q1 24 | — | $492.8M |
净利润CBLLMASI
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $-100.4M | ||
| Q2 25 | $-13.6M | $51.3M | ||
| Q1 25 | $-12.8M | $-170.7M | ||
| Q4 24 | — | $-349.6M | ||
| Q3 24 | $-10.4M | $9.8M | ||
| Q2 24 | — | $16.0M | ||
| Q1 24 | — | $18.9M |
毛利率CBLLMASI
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | 62.1% | ||
| Q2 25 | 88.1% | 62.9% | ||
| Q1 25 | 87.9% | 62.9% | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | 87.3% | 52.2% | ||
| Q2 24 | — | 51.3% | ||
| Q1 24 | — | 49.0% |
营业利润率CBLLMASI
| Q4 25 | -58.9% | — | ||
| Q3 25 | -64.8% | 22.5% | ||
| Q2 25 | -70.5% | 17.4% | ||
| Q1 25 | -69.3% | 21.0% | ||
| Q4 24 | — | -59.8% | ||
| Q3 24 | -57.8% | 6.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 6.9% |
净利率CBLLMASI
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | -27.0% | ||
| Q2 25 | -64.4% | 13.8% | ||
| Q1 25 | -62.4% | -45.9% | ||
| Q4 24 | — | -58.2% | ||
| Q3 24 | -60.6% | 1.9% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 3.8% |
每股收益（稀释后）CBLLMASI
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.37 | $-1.84 | ||
| Q2 25 | $-0.38 | $0.94 | ||
| Q1 25 | $-0.36 | $-3.12 | ||
| Q4 24 | — | $-6.54 | ||
| Q3 24 | $-1.85 | $0.18 | ||
| Q2 24 | — | $0.29 | ||
| Q1 24 | — | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | $312.3M |
| 总债务越低越好 | — | $559.1M |
| 股东权益账面价值 | $155.3M | $810.0M |
| 总资产 | $195.8M | $1.8B |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资CBLLMASI
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | $312.3M | ||
| Q2 25 | $177.4M | $149.6M | ||
| Q1 25 | $182.7M | $130.8M | ||
| Q4 24 | — | $177.6M | ||
| Q3 24 | $14.1M | $158.5M | ||
| Q2 24 | — | $129.6M | ||
| Q1 24 | — | $157.6M |
总债务CBLLMASI
| Q4 25 | — | — | ||
| Q3 25 | — | $559.1M | ||
| Q2 25 | — | $613.7M | ||
| Q1 25 | — | $651.0M | ||
| Q4 24 | — | $765.2M | ||
| Q3 24 | — | $772.6M | ||
| Q2 24 | — | $781.6M | ||
| Q1 24 | — | $876.0M |
股东权益CBLLMASI
| Q4 25 | $155.3M | — | ||
| Q3 25 | $164.1M | $810.0M | ||
| Q2 25 | $172.2M | $1.0B | ||
| Q1 25 | $180.9M | $946.4M | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $-136.0M | $1.5B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
总资产CBLLMASI
| Q4 25 | $195.8M | — | ||
| Q3 25 | $199.5M | $1.8B | ||
| Q2 25 | $207.7M | $2.4B | ||
| Q1 25 | $213.5M | $2.3B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | $47.1M | $3.1B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $3.0B |
负债/权益比CBLLMASI
| Q4 25 | — | — | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $56.8M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | $50.9M |
| 自由现金流率自由现金流/营收 | -44.2% | 13.7% |
| 资本支出强度资本支出/营收 | 0.7% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.6M | $191.0M |
8季度趋势，按日历期对齐
经营现金流CBLLMASI
| Q4 25 | $-10.8M | — | ||
| Q3 25 | $-11.1M | $56.8M | ||
| Q2 25 | $-7.5M | $69.4M | ||
| Q1 25 | $-11.4M | $31.1M | ||
| Q4 24 | — | $50.5M | ||
| Q3 24 | — | $25.6M | ||
| Q2 24 | — | $74.5M | ||
| Q1 24 | — | $45.8M |
自由现金流CBLLMASI
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | $50.9M | ||
| Q2 25 | $-7.6M | $65.6M | ||
| Q1 25 | $-11.6M | $28.5M | ||
| Q4 24 | — | $46.0M | ||
| Q3 24 | — | $16.9M | ||
| Q2 24 | — | $66.9M | ||
| Q1 24 | — | $37.6M |
自由现金流率CBLLMASI
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | 13.7% | ||
| Q2 25 | -35.9% | 17.7% | ||
| Q1 25 | -56.4% | 7.7% | ||
| Q4 24 | — | 7.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | — | 7.6% |
资本支出强度CBLLMASI
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | 1.6% | ||
| Q2 25 | 0.3% | 1.0% | ||
| Q1 25 | 0.7% | 0.7% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% |
现金转化率CBLLMASI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.35× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.61× | ||
| Q2 24 | — | 4.66× | ||
| Q1 24 | — | 2.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
MASI
暂无分部数据
